CLOROX CO /DE/ Financials
Quarterly XBRL submissions from SEC 10-K and 10-Q filings.
Income Statement (Last 8 Quarters)
(3)| Period | Revenue | YoY % | Net Income | YoY % | Operating Income | EPS |
|---|---|---|---|---|---|---|
| Q1 FY202610-Q · 2025-09-30 | $1.4B | — | $80.0M | — | — | $0.65 |
| Q3 FY202510-Q · 2025-03-31 | $263.0M | — | $186.0M | — | — | $1.50 |
| Q2 FY202510-Q · 2024-12-31 | $1.7B | — | $193.0M | — | — | $1.54 |
Balance Sheet
| Period | Total Assets | Total Liabilities | Cash & Equivalents | Shareholders Equity |
|---|---|---|---|---|
| Q1 FY202610-Q | $5.5B | $5.4B | $166.0M | -$22.0M |
| Q3 FY202510-Q | $5.5B | $5.3B | $226.0M | -$252.0M |
| Q2 FY202510-Q | $5.6B | $2.7B | $8.0M | -$41.0M |
Cash Flow Highlights
| Period | Operating Income | Net Income | Gross Profit | Shares Outstanding |
|---|---|---|---|---|
| Q1 FY202610-Q | — | $80.0M | $596.0M | 121,775,608 |
| Q3 FY202510-Q | — | $186.0M | $744.0M | 130,741,000 |
| Q2 FY202510-Q | — | $193.0M | $738.0M | 130,741,000 |
Filings
(4)Methodology
Every figure on this page is pulled directly from CLOROX CO /DE/'s own XBRL submissions to the U.S. Securities and Exchange Commission. XBRL is the standardized tagging format the SEC requires for line items in 10-K and 10-Q filings, which means revenue, net income, and balance-sheet entries are reported by the company itself — not estimated by us.
Cayman Journal reconciles preferred GAAP tags (for example, Revenues, RevenueFromContractWithCustomerExcludingAssessedTax) and normalizes them so quarter-over-quarter comparability is preserved. Our automated ingestion runs nightly; markets editors spot-check flagged anomalies before they appear on the public hub. Where a tag is missing for a given period, we surface an em dash rather than impute a value.
Source documents are linked under Filings above and point to the original EDGAR submission index. Errors should be reported to [email protected].